Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lobaplatin + 5-fluorouracil neoadjuvant chemotherapy followed by concurrent lobaplatin with IMRT for locoregionally advanced nasopharyngeal carcinoma
ChiCTR-ONC-12002060Phase 2Completed
- Sponsor
- Sun Yat-sen University Cancer Center
- Start
- Apr 2012
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lobaplatin and fluorouracil in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University Cancer Center. Primary endpoint: Objective response rate. Started Apr 2012; status: completed.
02
Drugs
lobaplatinfluorouracil
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on ChiCTR-ONC-12002060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-12002060.